Science Explorer Interactive view Map

EpiVax (United States)

Research works
83
▼ 14% vs 2013–17
Citations
2k
23.7 per fractional work
Top-10% rate
24.8%
record average 16.5%
Open access
55%
world 28%

Not ranked overall: EpiVax (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.85× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.96× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 22.89× its world share, 2 worksImmunology and Micro…Computer Science: 0.08× its world share, 0 worksComputer ScienceHealth Professions: 1.45× its world share, 0 worksHealth ProfessionsMedicine: 2.01× its world share, 4 worksMedicineEconomics, Econometrics and Finance: 1.86× its world share, 0 worksEconomics, Econometr…Psychology: 0.87× its world share, 0 worksPsychologySocial Sciences: 0.16× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 22.9×. Every wedge is a field page.

Who are the top researchers at EpiVax (United States)?

Ranked on the composite score, Anne S. De Groot lead among researchers whose main affiliation is EpiVax (United States).

  1. 1 Anne S. De Groot United States · #923,229 worldwide 76 citations · 44 works
All ranked researchers at EpiVax (United States)

Which keywords describe research at EpiVax (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Antigen Presentation, Epitope Prediction, Peptide-MHC Binding, Monoclonal Antibodies, Immunity, Cancer Immunotherapy, Glycosylation and Epidemiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Antigen Presentation20▲ 246×2 topics
  2. Epitope Prediction13▲ 857×1 topic
  3. Peptide-MHC Binding13▲ 857×1 topic
  4. Epidemiology12▲ 3.5×32 topics
  5. Monoclonal Antibodies11▲ 91×3 topics
  6. Immunity10▲ 35×4 topics
  7. Cancer Immunotherapy8▲ 73×3 topics
  8. Glycosylation8▲ 46×3 topics
  9. Therapeutic Antibodies8▲ 76×2 topics
  10. Innate Immunity8▲ 27×4 topics
  11. Antibody Engineering8▲ 92×1 topic
  12. Fc Receptors8▲ 92×1 topic
  13. Dendritic Cells7▲ 75×2 topics
  14. Tumor Antigen7▲ 105×1 topic
  15. Vaccine Adjuvants7▲ 105×1 topic
  16. Vaccine7▲ 21×11 topics
  17. Pathogenesis7▲ 14×11 topics
  18. Pandemic6▲ 15×6 topics
  19. Immune Response5▲ 10×10 topics
  20. Biopharmaceuticals5▲ 82×3 topics
  21. Autoimmunity4▲ 25×3 topics
  22. Antibodies4▲ 55×2 topics
  23. Genomics4▲ 14×4 topics
  24. Foxp34▲ 57×1 topic
  25. TGF-ß4▲ 25×1 topic
  26. Virus4▲ 35×3 topics
  27. Immunogenicity3▲ 75×2 topics
  28. Cell Culture3▲ 33×2 topics
  29. Vaccine Development3▲ 11×8 topics
  30. Vaccines3▲ 50×2 topics
  31. Clinical Outcomes3▲ 17×2 topics
  32. Coronavirus3▲ 28×3 topics
  33. Drug Resistance3▲ 11×4 topics
  34. H1N13▲ 92×1 topic
  35. Influenza3▲ 70×1 topic
  36. Mutation3▲ 21×2 topics
  37. Bioanalytical Methods3▲ 217×1 topic
  38. Biosimilars3▲ 217×1 topic
  39. Viral Transmission3▲ 32×2 topics
  40. Bioprinting2▲ 66×1 topic

Which research topics does EpiVax (United States) publish most on?

By volume in 2022–2025: vaccines and immunoinformatics approaches, Biosimilars and Bioanalytical Methods, Monoclonal and Polyclonal Antibodies Research and Immunotherapy and Immune Responses.

  1. 1 vaccines and immunoinformatics approaches Molecular Biology 2 works
  2. 2 Biosimilars and Bioanalytical Methods Immunology 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Immunotherapy and Immune Responses Immunology 1 works
  5. 5 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  6. 6 Animal Virus Infections Studies Animal Science and Zoology 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 Virus-based gene therapy research Genetics 0 works
  9. 9 Influenza Virus Research Studies Epidemiology 0 works
  10. 10 T-cell and B-cell Immunology Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.7%not open45.3%

World: 28% of research is openly available.

with international co-authors19.5%domestic only80.5%

World: 19% is written across borders.

How has EpiVax (United States)'s research output changed?

Output in 2018–2022 was 14% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Providence

All research institutions in Providence

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.